• 1
    Hare E. Tumor involving certain nerves. London Medical Gas. 1838; 1: 16-18.
  • 2
    Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg. 2001; 121: 472-483.
  • 3
    Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 2007; 25: 313-318.
  • 4
    Arcangeli G, Mauro F, Morelli D, Nervi C. Multiple daily fractionation in radiotherapy: biological rationale and preliminary clinical experiences. Eur J Cancer. 1979; 15: 1077-1083.
  • 5
    Rusch VW, Parekh KR, Leon L, et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg. 2000; 119: 1147-1153.
  • 6
    Kunitoh H, Kato H, Tsuboi M, et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol. 2008; 26: 644-649.
  • 7
    National Comprehensive Cancer Network Clinical Guidelines for Non-Small Cell Lung Cancer, vol. 2.2010. Available at: Accessed on December 21, 2009.
  • 8
    Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005; 366: 643-648.
  • 9
    Kwong KF, Edelman MJ, Suntharalingam M, et al. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival. J Thorac Cardiovasc Surg. 2005; 129: 1250-1257.
  • 10
    Suntharalingam M, Sonett JR, Haas ML, et al. The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors. Cancer J. 2000; 6: 365-371.
  • 11
    Komaki R, Roth JA, Walsh GL, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 2000; 48: 347-354.
  • 12
    Cox JD, Stanley K, Petrovich Z, Paig C, Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA. 1981; 245: 469-472.
  • 13
    Russell AH, Pajak TE, Selim HM, et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1991; 21: 637-643.
  • 14
    Umsawasdi T, Valdivieso M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol. 1984; 2: 253-259.
  • 15
    Gore EM, Bae S, Wong S, et al. A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: initial analysis of Radiation Therapy Oncology Group 0214 [abstract]. J Clin Oncol. 2008; 27( 15 suppl). Abstract 7506.
  • 16
    Detterbeck FC. Pancoast (superior sulcus) tumors. Ann Thorac Surg. 1997; 63: 1810-1818.
  • 17
    Komaki R, Roh J, Cox JD, Lopes da Conceicao A. Superior sulcus tumors: results of irradiation of 36 patients. Cancer. 1981; 48: 1563-1568.
  • 18
    Topkan E, Yildirim BA, Selek U, Yavuz MN. Cranial prophylactic irradiation in locally advanced non-small cell lung carcinoma: current status and future perspectives. Oncology. 2009; 76: 220-228.